Latin America Peripheral Vascular Devices Market Research Report – Segmented By Product Type, Material, Stents, Devices and Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis From 2026 to 2034

ID: 2011
Pages: 135

Market Size, 2025

$1164.61 Mn

Market Estimate, 2026

$1256.96 Mn

Market Forecast, 2034

$2314.51 Mn

CAGR, 2026–2034

7.93%

Latin America Peripheral Vascular Devices Market Size, Growth, Trends & Forecast (2026–2034)

The Latin America peripheral vascular devices market size was valued at USD 1,164.61 million in 2025, is anticipated to reach USD 1,256.96 million in 2026, and is projected to scale up to USD 2,314.51 million by 2034, registering a compound annual growth rate (CAGR) of 7.93% during the forecast period from 2026 to 2034. Driven by a rising geriatric population, increasing prevalence of peripheral vascular disorders and diabetes, growing demand for minimally invasive procedures, and technological advancements in stent manufacturing, the Latin American sector continues to record solid expansion.

Key Executive Metrics (At-a-Glance)

  • 2025 Base Valuation: USD 1,164.61 Million
  • 2026 Current Valuation: USD 1,256.96 Million
  • 2034 Forecast Valuation: USD 2,314.51 Million
  • Compound Annual Growth Rate (CAGR): 7.93% (2026–2034)
  • Dominant Market Share (Regional): Brazil (held the largest market share in LATAM, backed by government reimbursement and industrialization)
  • Key Growth Markets: Argentina, Chile, and Mexico (propelled by rising chronic disease incidence and medical tourism)

Core Market Drivers

  • Demographic Pressures: A rapidly aging population scaling up the incidence of Peripheral Arterial Disease (PAD) and related vascular complications.
  • Technological Improvements: Innovations in stent manufacturing minimizing neointimal hyperplasia, alongside advanced endovascular aneurysm repair (EVAR) platforms.
  • Lifestyle Factors: Unhealthy dietary habits, heavy alcohol intake, and smoking increasing the risk of atherosclerotic plaques and blood clotting disorders.

Primary Market Restraints & Challenges

  • Product Issues: Occasional product failures, recalls, and the availability of alternative therapeutic options.
  • Logistical Constraints: Supply chain disruptions and surgical backlogs stemming from pandemic-related slowdowns.

Latin America Peripheral Vascular Devices Market Segmentation Highlights

Segment CategoryLargest Market SegmentFastest-Growing Market Segment
By Product TypeStents (Peripheral Stents)Peripheral Accessories & Hemodynamic Flow Alteration Devices
By MaterialResistant MaterialsSemi-Consistent Sorts
By CountryBrazil (Market Leader)Brazil & Mexico

Major Industry Players Profiled

Promising companies dominating the LATAM peripheral vascular devices market include Abbott Laboratories, Cordis Corporation, Medtronic, Inc., Boston Scientific Corporation, and Covidien, Inc.

To learn more about this report, icon Download Free Sample Report

Latin America Peripheral Vascular Devices Market Size

The Latin America peripheral vascular device market size was valued at USD 1164.61 million in 2025 and is anticipated to reach USD 1256.96 million in 2026 from USD 2314.51 million by 2034, growing at a CAGR of 7.93% during the forecast period from 2026 to 2034.

The peripheral vascular device is utilized as a part of the treatment of blood vessels outside the heart and brain. The increasing rise of the elderly population and the related increase in the prevalence of peripheral vascular disorders, the approval of new and improved devices, and the rising incidence of diabetes are key factors driving the peripheral vascular devices market forward in the Latin American region. In addition, stent restenosis problems caused by neovascularization and neointimal hyperplasia at the implant site have been reduced due to advances in stent manufacturing techniques. This is also helping to drive up the demand for stents. Stents are utilized to treat peripheral vascular disorders; hence their rising demand propels the market forward. The rate of occurrence of peripheral vascular diseases has increased in Brazil due to industrialization and the rise in the geriatric population. In addition, the government of the country provides reimbursement services to patients. This is likely to increase the number of patients seeking treatment for Peripheral Vascular Devices, boosting the Brazilian market for peripheral vascular devices.

The availability of alternative treatments and product failures and recalls are projected to restrict the market's growth throughout the forecast period.

With the population aging, PAD (Peripheral Vascular Device) is projected to become more widespread in the future. As a result, statistics suggest that the number of people with PAD is increasing quicker, driving the peripheral arterial disease market. Other causes, such as the growing need for minimally invasive procedures, particularly for peripheral arterial disease, lifestyle changes, and technical improvements, have expanded the peripheral vascular device range. Furthermore, by increasing the incidence rates of cardiac arrest, blood clotting, and other vascular disorders, disease-causing lifestyle and eating habits such as heavy alcohol intake, tobacco products, and smoking cigarettes are predicted to enhance Latin America's peripheral vascular device market demand.

There was also a disturbance in the supply chain and a slowdown in production due to lockdowns. As a result, medical device procurement and surgical resource availability were delayed. As a result, the COVID-19 pandemic poses a threat to the peripheral vascular devices business, restricting its growth temporarily.

Peripheral vascular diseases, obesity, and diabetes, to name a few, are becoming more common in Brazil. As a result, there has been an increase in the demand for stent implants. In addition, junk food consumption and smoking behaviors are becoming more common. This results in the production of atherosclerotic plaques, which raises the risk of stroke. Endologix is a medical device company specializing in developing, manufacturing, and distributing medical devices to treat aortic disorders. The company's solutions are designed to treat abdominal aortic aneurysms (AAA) via minimally invasive surgery. They are being developed on two platforms: endovascular aneurysm sealing (EVAS) and endovascular aneurysm repair. In addition, Argentina's medical tourism industry is booming, with most visitors coming from outside Latin America. For these individuals, peripheral vascular therapies are one of the most popular options. As a result of these factors, the peripheral vascular device market is likely to grow during the forecast period.

KEY MARKET PLAYERS

Promising companies dominating the LATAM Peripheral Vascular Devices market include Abbott Laboratories (U.S.), Cordis Corporation (U.S.), Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), and Covidien, Inc. (U.S.).

MARKET SEGMENTATION

This research report on the Latin America Peripheral Vascular Devices Market has been segmented & sub-segmented into the following categories.

By Product Type

  • Stents
    • Balloon-Expandable Stent
    • Self-Expandable Stents
    • Secured Stents
  • Embolic Protection Devices
  • Angioplasty Balloons
    • Ordinary
    • Cutting
    • Scoring
    • Medication
  • Aortic Stent-Grafts
  • Inferior Vena Cava Filters
  • Synthetic Surgical Grafts
  • Peripheral Vascular Accessory Devices
  • Vascular Closure Devices
  • Chronic Total Occlusion (CTO) Devices
  • PTA Balloon Catheters

By Material

  • Resistant
  • Semi-Consistent Sorts

By Country

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Related Reports

Click for Request Sample